- Secured the largest order from a single customer in Company history with a new order from bp (NYSE:BP) for deployment across the United States, United Kingdom, Europe, and Australia.
Piper Sandler Maintains Overweight on Cytek Biosciences, Raises Price Target to $16
Piper Sandler analyst David Westenberg maintains Cytek Biosciences (NASDAQ:CTKB) with a Overweight and raises the price target from $12 to $16.